M. Ashworth Richard's most recent trade in Amedisys Inc. was a trade of 114,055 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 114,055 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 62,641 | 0 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 62,641 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 62,641 | 62,641 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 45,870 | 114,055 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 39,850 | 0 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 39,850 | 0 (0%) | 0% | - | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 39,850 | 39,850 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2025 | 22,474 | 0 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 58,316 | 159,925 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.96 per share. | 27 Dec 2024 | 11,079 | 101,609 (0%) | 0% | 90.0 | 996,667 | Common Stock |
| Amedisys Inc. | M. Ashworth Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 55,175 | 112,688 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.82 per share. | 26 Dec 2023 | 11,237 | 67,653 (0%) | 0% | 79.8 | 896,937 | Common Stock |
| Amedisys Inc. | Richard Ashworth M. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 11,237 | 22,474 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Ashworth Richard M. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.14 per share. | 26 Dec 2023 | 10,140 | 57,513 (0%) | 0% | 95.1 | 964,720 | Common Stock |
| Amedisys Inc. | M. Ashworth Richard | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.54 per share. | 21 Dec 2023 | 17,976 | 56,416 (0%) | 0% | 95.5 | 1,717,427 | Common Stock |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 27,410 | 74,392 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 62,641 | 62,641 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 33,711 | 33,711 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 31,321 | 31,321 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 31,321 | 31,321 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Richard M. Ashworth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 15,661 | 46,982 (0%) | 0% | 0 | Common Stock |